Strata Critical Medical Depreciation & Amortization Growth & History (SRTA)
Strata Critical Medical's depreciation and amortization was $8.2M for fiscal 2025.
View full Strata Critical Medical company overviewStrata Critical Medical annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.2M | $2.2M | +37.29% |
| 2024 | 2024-12-31 | $6.0M | −$1.1M | −16.16% |
| 2023 | 2023-12-31 | $7.1M | $1.4M | +24.21% |
| 2022 | 2022-12-31 | $5.7M | — | — |
| 2021 | 2021-09-30 | $596,000 | $70,000 | +13.31% |
| 2020 · Sep 30 | 2020-09-30 | $526,000 | $54,000 | +11.44% |
| 2019 · Sep 30 | 2019-09-30 | $472,000 | — | — |
Strata Critical Medical quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.5M | $6.7M | +379.45% |
| Q1 2026 | 2026-03-31 | $3.1M | $1.4M | +80.32% |
| Q4 2025 | 2025-12-31 | $3.0M | — | — |
| Q3 2025 | 2025-09-30 | $1.7M | $425,000 | +33.23% |
| Q2 2025 | 2025-06-30 | $1.8M | $217,000 | +13.92% |
| Q1 2025 | 2025-03-31 | $1.7M | $103,000 | +6.46% |
| Q3 2024 | 2024-09-30 | $1.3M | −$564,000 | −30.60% |
| Q2 2024 | 2024-06-30 | $1.6M | −$251,000 | −13.87% |
| Q1 2024 | 2024-03-31 | $1.6M | −$58,000 | −3.51% |
| Q3 2023 | 2023-09-30 | $1.8M | $402,000 | +27.90% |
| Q2 2023 | 2023-06-30 | $1.8M | $655,000 | +56.71% |
| Q1 2023 | 2023-03-31 | $1.7M | $507,000 | +44.28% |
| Q3 2022 · Sep 30 | 2022-09-30 | $1.4M | $1.3M | +654.45% |
| Q3 2022 · Jun 30 | 2022-06-30 | $1.2M | $1.0M | +725.00% |
| Q2 2022 | 2022-03-31 | $1.1M | $1.0M | +808.73% |
| Q1 2022 | 2021-12-31 | $717,000 | — | — |
| Q4 2021 | 2021-09-30 | $191,000 | — | — |
| Q2 2021 | 2021-06-30 | $140,000 | — | — |
| Q1 2021 | 2021-03-31 | $126,000 | — | — |
Strata Critical Medical depreciation and amortization trends
Between the periods ended 2019-09-30 and 2025-12-31, Strata Critical Medical's depreciation and amortization increased from $472,000 to $8.2M, a change of $7.7M. The latest reported quarter, Q2 2026, shows $8.5M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Strata Critical Medical source filings ↗